Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has increased by 2.10%
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 02, 2024, titled "Dr. Reddy s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries . | Download
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 02, 2024, titled "Dr. Reddy s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries . | Download
Final • Div/Share: ₹ 40
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant